Out-licensing
Up-to-date access to technology licensing opportunities worldwide.
- Out-licensing
- Browse
Licensing opportunities
Aerosolized immunogenic compositions that may prove useful for vaccination against respiratory infections and may provide a platform for generating mucosal antibody responses against other pathogens. More
Related Reports
Market Research Reports provided by reports.iptechex.com
Nov 2010 - 160 pages - $1,495
Jan 2011 - 33 pages - $500
Dec 2010 - 48 pages - $1,000
Jul 2011 - 82 pages - $500
Apr 2010 - 139 pages - $3,800
Apr 2011 - 24 pages - $1,000
Mar 2008 - 123 pages - $3,800
Feb 2010 - 220 pages - $4,200
Feb 2011 - 26 pages - $5,700
Nov 2011 - 168 pages - $3,835
Your selection
Browse By
- Industry sector
- Generics
- Nutrition
- OTC/Non-Prescription
- Pediatric
- Personal Care
- Prescription
- Development phase
- Early Stage
- Preclinical
- Phase I
- Phase I/II
- Phase II
- Phase III
- Phase III/IV
- Preregistration
- Registered
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us